Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-03-11
1998-03-03
Prior, Kimberly J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514172, 514173, 514174, 514176, 514177, 514178, 514182, 540 6, 540 23, 540 31, 540 45, 540 51, 552502, 552508, 552540, 552544, 552548, 552552, 552553, 552555, 552557, 552559, 552582, 552592, 552596, 552598, 552599, 552603, 552604, 552607, 552608, 552609, 552610, 552611, 552612, 552632, 552633, 552634, 552635, 552638, 552639, 552640, 552641, 552642, 552643, 552646, 552648, 552649, 552650, 552651, 552652, C07J 7100, C07J 100, A61K 3158, A61K 31565
Patent
active
057234558
ABSTRACT:
Novel antiandrogenic agents are provided. An exemplary group of compounds has the structural formula (I) ##STR1## wherein R.sup.1 through R.sup.10, a and b are as defined herein. Pharmaceutical compositions and methods for using the compounds of formula (I) to treat androgen-related clinical conditions are provided, as are methods and compositions for using the compounds as contraceptive agents.
REFERENCES:
patent: 4150127 (1979-04-01), Anner et al.
patent: 4412993 (1983-11-01), Sokolowski
patent: 4456600 (1984-06-01), Wiechert et al.
patent: 4558041 (1985-12-01), Wiechert et al.
patent: 4673673 (1987-06-01), Laurent et al.
patent: 4874754 (1989-10-01), Nique et al.
patent: 4891365 (1990-01-01), Wiechert et al.
patent: 4892867 (1990-01-01), Wiechert et al.
G. Ohta et al., "Investigations on Steroids. IV. Syntheses of 13:1445-1459 (1965).
Ferrari et al, "Endocrine Profile of Topterone, a Topical Antiandrogen, in Three Species of Laboratory Animals", Meth and Find Exptl Clin Pharmacol 2(2):65-69 (1980).
R.A. Edgren et al., "Biological Effects of Synthetic Gonanes," Recent Progress in Hormone Research (1966) 22:305-341.
S. Nakajin et al., "Inhibitory Effect and Interaction of Stanozolol with Pig Testicular Cytochrome P-450 (17.alpha.-Hydroxylase/C.sub.17,20 -Lyase)," Chem. Pharm. Bull. (1989) 37(7):1855-1858
T. Ojasoo et al., "Towards the Mapping of the Progesterone and Androgen Receptors," J. Steroid Biochem. (1987) 27(1-3):255-269.
L.L. Smith, "Absorption Spectra of Substituted .increment..sup.4 -3-Ketosteroids in Concentrated sulfuric Acid. III. 19-Nor Series," Tex. Reports Biol. Med. (1966) 24(4):674-692.
C.H. Spilman et al. "Relationship between Progesterone Receptor Binding and Progestin Biological Activity," J. Steroid Biochem. (1985) 22(3):289-292.
K. Tanayama et al. "Disposition and Metabolism of 16.beta.-Ethyl-17.beta.-Hydroxy-4-Estren-3-One (TSAA-291), a New Antiandrogen, in Rats," Steroids (1979) 65-83.
K. Ueno et al. "Investigation on Steroids. VIII. Synthesis of steroidal 15(4):523-527.
Chao Wan-Ru
Chong Wesley K. M.
Crowe David F.
Tanabe Masato
Prior Kimberly J.
Reed Dianne E.
SRI - International
LandOfFree
Antiandrogenic agents and related pharmaceutical compositions an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiandrogenic agents and related pharmaceutical compositions an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiandrogenic agents and related pharmaceutical compositions an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2247786